Lpl Financial LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Lpl Financial LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.19 - $0.3 $228 - $360	-1,200 Reduced 0.2%	612,328 $165,000
Q4 2023 Feb 14, 2024	SELL	$0.12 - $0.64 $480 - $2,560	-4,000 Reduced 0.65%	613,528 $134,000
Q3 2023 Nov 13, 2023	SELL	$0.12 - $0.41 $360 - $1,230	-3,000 Reduced 0.48%	617,528 $80,000
Q2 2023 Jul 31, 2023	SELL	$0.35 - $0.72 $5,040 - $10,368	-14,400 Reduced 2.27%	620,528 $223,000
Q4 2022 Feb 07, 2023	BUY	$0.46 - $42.69 $6,900 - $640,350	15,000 Added 2.42%	634,928 $317,000
Q3 2022 Nov 14, 2022	BUY	$0.63 - $33.0 $223,599 - $11.7 Million	354,920 Added 133.93%	619,928 $394,000
Q2 2022 Aug 12, 2022	SELL	$0.63 - $0.96 $491 - $748	-780 Reduced 0.29%	265,008 $209,000
Q1 2022 May 16, 2022	SELL	$0.5 - $1.06 $5,948 - $12,609	-11,896 Reduced 4.28%	265,788 $214,000
Q3 2021 Nov 15, 2021	BUY	$0.67 - $1.51 $81,556 - $183,806	121,726 Added 78.05%	277,684 $361,000
Q2 2021 Aug 13, 2021	BUY	$0.75 - $1.1 $2,385 - $3,498	3,180 Added 2.08%	155,958 $121,000
Q1 2021 May 14, 2021	BUY	$0.96 - $1.74 $17,546 - $31,803	18,278 Added 13.59%	152,778 $160,000
Q4 2020 Feb 12, 2021	BUY	$0.76 - $1.47 $102,220 - $197,715	134,500 New	134,500 $183,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.